10095801TCRlcLNP - Combining long-circulating Lipid Nanoparticles with cancer-targeting T-Cell Receptors to better deliver immunotherapies in the tumour microenvironment.ActiveCollaborative R&DInnovate UKTCRlcLNP - Combining long-circulating Liquid Nanoparticles with cancer-targeting T-Cell Receptors to better deliver immunotherapies in the tumour microenvironment.